一、会议召开和出席情况 （一）股东大会召开的时间：2025年11月14日 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688213 证券简称：思特威 公告编号：2025-041 思特威（上海）电子科技股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次会议是否有被否决议案：无 （二）股东大会召开的地点：上海市闵行区田林路889号科技绿洲四期8号楼 （三）出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及其持有表决权数量的情 况： ■ （四）表决方式是否符合《公司法》及公司章程的规定，大会主持情况等。 本次股东大会由公司董事会召集，董事长徐辰先生主持，会议采用现场投票和网络投票相结合的表决方 式。本次股东大会的召集和召开程序、出席会议人员的资格和召集人资格、会议的表决程序和表决结果 均符合《中华人民共和国公司法》及《思特威（上海）电子科技股份有限公司章程》的规定。 （五）公司董事、监事和董事会秘书的出席情况 1、公司在任董事9人 ...

Core Viewpoint - The company has released its third-quarter financial report for 2025, highlighting significant changes in various financial metrics and a proposed profit distribution plan for shareholders [3][20]. Financial Data Summary - The company reported a net profit attributable to the parent company of 50,994,951.12 yuan for the first three quarters of 2025, with a total distributable profit of 1,145,248,626.67 yuan [20]. - Total revenue for the reporting period decreased by 9.25% compared to the same period last year, primarily due to a reduction in order volume [5]. - The company’s cash flow from operating activities decreased by 138.43% year-on-year, attributed to a reduction in cash received from customers [6]. Changes in Financial Metrics - Accounts receivable decreased by 40.23% compared to the beginning of the year, mainly due to a reduction in received bills [5]. - Prepayments increased by 55.79%, reflecting payments for materials and equipment not yet received [5]. - Inventory increased by 39.57%, indicating a rise in goods shipped but not yet recognized as revenue [5]. - Long-term equity investments surged by 227.23%, attributed to investments in joint ventures [5]. - Short-term borrowings increased by 45.01%, reflecting higher financing needs [5]. Profit Distribution Plan - The company plans to distribute 0.4 yuan per share (including tax) to shareholders, amounting to a total of 13,213,004 yuan [20]. - The distribution will be based on a total share capital of 330,325,100 shares after accounting for repurchased shares [20]. - The profit distribution plan is designed to ensure sufficient liquidity for the company while providing returns to shareholders [21]. Board Meeting and Management Changes - The board of directors held a meeting on October 29, 2025, where the third-quarter report and profit distribution plan were approved unanimously [15]. - The company appointed a new head of the audit department following the resignation of the previous manager [23].

Core Viewpoint - The company held its 13th meeting of the second board of directors on October 25, 2025, where several key resolutions were passed, including the approval of the Q3 2025 report, a three-year dividend plan, a profit distribution proposal, and the reappointment of the accounting firm for 2025 [1][2][5][50]. Group 1: Q3 2025 Report - The board approved the Q3 2025 report, confirming that it complies with legal requirements and accurately reflects the company's situation without any misleading statements or omissions [2][3]. Group 2: Dividend Plan - The company established a three-year dividend return plan for 2025-2027 to enhance transparency and protect minority shareholders' rights [5][6]. Group 3: Profit Distribution Proposal - The company proposed a cash dividend of RMB 3.60 per 10 shares, totaling RMB 144,003,600.00, based on a total share capital of 400,010,000 shares [9][10][40]. - The profit distribution plan is based on the company's net profit of RMB 483,469,539.81 for the first three quarters of 2025, with unallocated profits amounting to RMB 1,595,209,912.95 [40][43]. Group 4: Reappointment of Accounting Firm - The board proposed to reappoint Huaxing Accounting Firm for the 2025 financial year, which requires shareholder approval [50][59]. - The firm has a strong track record, having provided audit services to 91 listed companies in 2024, with a total revenue of RMB 37,037.29 million [52]. Group 5: Upcoming Shareholder Meeting - The company plans to hold its second extraordinary general meeting of 2025 on November 13, 2025, to discuss the aforementioned proposals [17][23]. - The meeting will allow for both on-site and online voting, ensuring broader participation from shareholders [24][25].

Core Viewpoint - The company has announced its profit distribution plan for the first three quarters of 2025, aiming to enhance shareholder returns while ensuring sufficient liquidity for operations and growth [20][21][24]. Financial Data - For the first nine months of 2025, the company reported a net profit attributable to shareholders of 1,470,738,960.56 yuan, with the parent company achieving a net profit of 953,611,770.21 yuan [21][24]. - The total distributable profit as of September 30, 2025, is 11,175,120,755.02 yuan, after accounting for previously paid cash dividends of 217,371,383.70 yuan [21][24]. Profit Distribution Plan - The proposed distribution plan suggests a cash dividend of 0.153 yuan per share (including tax) for every 10 shares held, which is expected to total approximately 100,515,842.14 yuan [21][22][24]. - The plan will be implemented within two months after approval at the shareholders' meeting, with adjustments made if the total share capital changes before the distribution [22][24]. Shareholder Engagement - The company emphasizes its commitment to enhancing shareholder returns and maintaining a long-term investment perspective, aligning with its operational and strategic goals [24][25]. - The board and supervisory committee have reviewed and approved the profit distribution plan, ensuring compliance with relevant regulations [26][27][41]. Clinical Trials and Product Development - The company is advancing its clinical trials for the SR604 injection, which has received regulatory approval for various phases, indicating ongoing investment in product development [14][17][18]. - The SR604 injection aims to address bleeding prevention in patients with hemophilia and has recently applied for additional indications [17][18]. Employee Stock Ownership Plan - The company has approved the unlocking of shares under its first employee stock ownership plan, reflecting its strategy to align employee interests with company performance [50][54]. - The plan's conditions have been met for a significant number of participants, indicating a successful implementation of the employee incentive strategy [50][54]. Strategic Direction - The company is focused on becoming a leading biopharmaceutical enterprise through innovation and strategic acquisitions, aiming for sustainable growth in the blood products industry [24][25]. - The dual strategy of internal growth and external acquisitions is designed to enhance operational capabilities and market position [24].

Core Points - The company held its 13th meeting of the second board on October 25, 2025, where several key resolutions were passed [1][2][5][30]. Group 1: Financial Reporting - The board approved the 2025 Q3 report, confirming that it accurately reflects the company's financial status without any misleading statements [2][9]. - The company reported a net profit of approximately 483.47 million yuan for the first three quarters of 2025, with undistributed profits at approximately 1.60 billion yuan [20][22]. Group 2: Profit Distribution Plan - The board proposed a profit distribution plan, suggesting a cash dividend of 3.60 yuan per 10 shares, totaling approximately 144 million yuan [10][20]. - The profit distribution plan is designed to balance immediate shareholder returns with the company's long-term growth [25][26]. Group 3: Auditor Appointment - The board approved the reappointment of Huaxing Accounting Firm for the 2025 fiscal year, pending shareholder approval [12][30]. - Huaxing Accounting Firm has a strong track record, having provided audit services to 91 listed companies in 2024 [32]. Group 4: Upcoming Shareholder Meeting - The company plans to hold its second extraordinary general meeting of 2025 on November 13, 2025, to discuss the approved resolutions [15][44]. - The meeting will allow for both on-site and online voting, ensuring broader participation from shareholders [47][48].

Group 1 - The company's stock experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 30% over three consecutive trading days (September 10, 11, and 12, 2025) [2] - The board of directors confirmed that there were no undisclosed significant matters that could impact the stock price, and no recent changes in the company's operational situation or external environment [2][3] - The company conducted inquiries with major stakeholders and found no violations of fair information disclosure regulations [2][3] Group 2 - The company held its first extraordinary general meeting of shareholders on September 12, 2025, with a total of 276 shareholders present, representing 250,491,626 shares, which is 54.0116% of the total voting shares [9][14] - The meeting approved the 2025 semi-annual profit distribution plan, with 99.9883% of the votes in favor [17] - Legal opinions were provided by Anhui Chengyi Law Firm, confirming that the meeting's procedures and resolutions were in compliance with legal and regulatory requirements [17]

Meeting Information - The meeting will be held on September 15, 2025, at 14:00, both in-person and online [2] - The in-person meeting location is the conference room 107, Henglin B District Office Building, Anji County, Huzhou City, Zhejiang Province [2] Agenda Items - The shareholders will review the following proposals: 1. Profit distribution plan for the first half of 2025 2. Proposal to abolish and revise certain management systems [3][6] Profit Distribution Plan - The company reported a net profit attributable to shareholders of 181,376,054.07 yuan for the first half of 2025 [6] - The proposed cash dividend is 5.50 yuan per 10 shares, totaling 76,486,867.05 yuan, which accounts for 42.17% of the net profit [6] Management System Revisions - The company plans to abolish the "Supervisory Committee Meeting Rules" and "Authorization Management System" and revise the "Behavior Norms of Controlling Shareholders and Actual Controllers" [7][8] - The new norms aim to enhance the governance structure and protect the rights of minority shareholders [9] Meeting Procedures - The meeting will follow a structured process including proposal reading, discussion, and voting [3][4] - Shareholders must register to speak or ask questions at least 10 minutes before the meeting starts [3] Voting and Decision Announcement - Voting will be conducted via a named voting system, and results will be announced after the meeting [4][5]

Meeting Overview - The second temporary shareholders' meeting of Anhui Tongguan Copper Foil Group Co., Ltd. was held on September 3, 2025, at 14:30 [1][2] - The meeting combined on-site voting and online voting [2] - The meeting was convened by the company's board of directors and presided over by Chairman Gan Guoqing [3][4] Attendance - A total of 688 shareholders attended the meeting, representing 602,228,612 shares, which is 72.9077% of the total voting shares [5] - Among them, 1 shareholder attended in person, representing 600,000,000 shares (72.6378%), while 687 shareholders participated via online voting, representing 2,228,612 shares (0.2698%) [5] - The attendance included company directors, supervisors, senior management, and a witnessing lawyer [6] Proposal Review and Voting Results - The meeting reviewed and approved the proposal regarding the 2025 interim profit distribution plan [7][8] - Total voting results showed that 602,089,621 shares (99.9769%) approved the proposal, while 101,491 shares (0.0169%) opposed it, and 37,500 shares (0.0062%) were abstained [8][9] - For minority shareholders, 2,089,621 shares (93.7633%) approved the proposal, 101,491 shares (4.5540%) opposed it, and 37,500 shares (1.6827%) abstained [8][16] Legal Opinion - Anhui Chengyi Law Firm provided a legal opinion confirming that the meeting's convening, procedures, attendance, proposals, voting processes, and results complied with relevant laws and regulations [10][14] - The legal opinion concluded that the resolutions passed at the meeting were valid and lawful [10][16] Documentation - The resolutions from the second temporary shareholders' meeting and the legal opinion from Anhui Chengyi Law Firm are available for review [11]

Group 1 - The Supervisory Board of Ananda Drive Technology (Shanghai) Co., Ltd. held its ninth meeting of the fourth session on August 28, 2025, with all three supervisors present, ensuring compliance with relevant laws and regulations [1][2]. - The Supervisory Board approved the 2025 semi-annual report and its summary, confirming that the report's preparation and review process adhered to legal and regulatory requirements, and the disclosed information accurately reflects the company's financial status and operational results [1][2]. - The Supervisory Board also approved the special report on the storage and actual use of raised funds for the first half of 2025, with unanimous support from all supervisors [2][3]. Group 2 - The profit distribution plan for the first half of 2025 was approved by the Supervisory Board, considering the company's operational situation and future funding needs, ensuring it does not harm the interests of the company or shareholders, particularly minority shareholders [2][3].

Group 1 - The company held its second board meeting of the ninth session, with all nine directors present, and the meeting complied with legal and regulatory requirements [2] - The board approved the provision for asset impairment, which aligns with accounting standards and reflects the company's financial status more accurately for the first half of 2025 [2][3] - The independent directors had no objections to the asset impairment provision [2] Group 2 - The company plans to distribute a cash dividend of 0.70 yuan per 10 shares, totaling approximately 49.82 million yuan, based on a total share capital of 711,707,933 shares after accounting for treasury shares [8][9] - The profit distribution plan is designed to balance immediate and long-term shareholder interests and is compliant with relevant laws and regulations [8][9] - The board will convene a third extraordinary general meeting to review additional proposals, with the date to be announced later [9]